MAM
Samsung launches TVC for Galaxy Grand
MUMBAI: Samsung has launched a new television commercial as a consumer connect initiative to showcase Galaxy Grand, the recently introduced Dual SIM Smartphone in India.
The TVC has been created by Leo Burnett.
The campaign is focused on creating a work life balance between personal and professional lives of youngsters.
The TVC creates synergy between the consumers and the features of the Galaxy Grand by showcasing aspirations, passions and hobbies of an ambitious and confident individual.
The TVC has been conceptualised to depict the Galaxy Grand’s Dual SIM feature wherein the professional is able to enjoy personal moments such as biking, moments with friends, mountaineering.
The TVC begins with a young male professional aspiring to live a Grand life by travelling on bike to see mountains kiss clouds, sky changing colours to every possible shade. He wishes to capture his memories with big screen experience and stay connected with his friends. Next thing one knows, he mentions about reserving special place to watch movies. A super appears in the foreground that reads: “Samsung Galaxy Grand”.
The TVC encourages younger generation to capture personal moments through technology purchase of the right Smartphone in spite of budgetary constraints and highlights top-end hardware and software features with a very attractive price of Galaxy Grand.
The TVC has been produced by Billoo Sandhu of Cutting Edge Pictures while it has been directed by Julien Trousselier.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
